Page last updated: 2024-10-20

pyrazinamide and Diabetic Glomerulosclerosis

pyrazinamide has been researched along with Diabetic Glomerulosclerosis in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kriki, P1
Thodis, E1
Deftereos, S1
Panagoutsos, S1
Theodoridis, M1
Kantartzi, K1
Mourvati, E1
Prassopoulos, P1
Passadakis, P1
Vargemezis, V1
Shichiri, M1
Iwamoto, H1
Shiigai, T1

Other Studies

2 other studies available for pyrazinamide and Diabetic Glomerulosclerosis

ArticleYear
A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient.
    Clinical nephrology, 2009, Volume: 71, Issue:6

    Topics: Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Ison

2009
Diabetic renal hypouricemia.
    Archives of internal medicine, 1987, Volume: 147, Issue:2

    Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Tubules; Male; Midd

1987